EMEA-002450-PIP01-18

Key facts

Active substance
Rifamycin
Decision number
P/0047/2019
PIP number
EMEA-002450-PIP01-18
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
Treatment of acute infectious diarrhoea
Route(s) of administration
Oral use
Contact for public enquiries
CRINOS S.P.A.

Tel. +39 0289421721
E-mail: regulatory.affairs@eglab.it

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating